What is the advantage of the AmpliChip® CYP450 Test?
The AmpliChip CYP450 Test is an all-in-one test that uses Nobel Prize-winning PCR and microarray technologies to detect CYP2D6 and CYP2C19 variations. The test offers high specificity with CYP2D6 gene deletions and duplications. The AmpliChip CYP450 Test is the first FDA-cleared test that can predict how an individual may respond to drugs that are metabolized by the CYP2D6 and CYP2C19 genes. This information can help clinicians make decisions with therapy, in particular with psychiatric medications that are known to be difficult to dose and that are metabolized by these pathways. The AmpliChip CYP450 Test is relevant and reliable. • It detects 27 allelic variations of CYP2D6; such a broad coverage of CYP2D6 makes the test relevant across a diverse patient base. • Unlike many other tests, it automatically checks that duplications of genes are functional, a feature that helps the resulting accuracy. Without such a feature, a test can wrongly classify a patient as an ultra-rapid metaboliz
